Successful Treatment of Unresectable Advanced Melanoma by Administration of Nivolumab With Ipilimumab Before Primary Tumor Resection

Ipilimumab, in combination with nivolumab, is one of the promising drugs that enhance the anti-tumor immune response of patients with advanced melanoma. Since the co-administration of nivolumab with ipilimumab in the neoadjuvant setting expands melanoma-reactive T cells at the primary site of melano...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Med (Lausanne)
Main Authors: Fujimura, Taku, Kambayashi, Yumi, Sato, Yota, Tanita, Kayo, Amagai, Ryo, Hashimoto, Akira, Hidaka, Takanori, Aiba, Setsuya
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6607934/
https://ncbi.nlm.nih.gov/pubmed/31297373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2019.00140
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados